Suchergebnisse
Neutron Q2 Earnings Call Highlights
Key Points
- Interested in Neutron Holdings, Inc.? Here are five stocks we like better.
- Record Q2 performance: Revenue rose 23.6% year over year to $304.2 million, while adjusted EBITDA increased
ViaSat (VSAT) Q1 Earnings Surpass Estimates
ViaSat (VSAT) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.17 per share a year ago. These figures are
Equitable Holdings, Inc. (EQH) Beats Q2 Earnings Estimates
Equitable Holdings, Inc. (EQH) came out with quarterly earnings of $1.7 per share, beating the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.1 per share a year ago
Voya (VOYA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2026, Voya Financial (VOYA) reported revenue of $269 million, down 24.4% over the same period last year. EPS came in at $1.51, compared to $2.40 in the year-ago quarter.
Compared to Estimates, Equitable Holdings (EQH) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2026, Equitable Holdings, Inc. (EQH) reported revenue of $3.73 billion, down 2% over the same period last year. EPS came in at $1.70, compared to $1.10 in the year-ago
Solid Power Q2 Earnings Call Highlights
Key Points
- Interested in Solid Power, Inc.? Here are five stocks we like better.
- Solid Power reported a $23.8 million second-quarter net loss and negative revenue of $300,000 after reversing
Red Rock Resorts Q2 Earnings Call Highlights
Key Points
- Interested in Red Rock Resorts, Inc.? Here are five stocks we like better.
- Second-quarter results declined year over year amid renovation and construction disruptions, with Las Vegas
Rigel Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Rigel Pharmaceuticals, Inc.? Here are five stocks we like better.
- Strong Q2 performance: Rigel reported $78.7 million in revenue and $17.3 million in net income, with
Ultragenyx Pharmaceutical Q2 Earnings Call Highlights
Key Points
- Interested in Ultragenyx Pharmaceutical Inc.? Here are five stocks we like better.
- Ultragenyx reported record Q2 revenue of $214 million, led by Crysvita’s $156 million contribution
Qualys Q2 Earnings Call Highlights
Key Points
- Interested in Qualys, Inc.? Here are five stocks we like better.
- Qualys raised its 2026 outlook after second-quarter revenue grew 11% to $182.2 million. The company now expects
PROCEPT BioRobotics Q2 Earnings Call Highlights
Key Points
- Interested in PROCEPT BioRobotics Corporation? Here are five stocks we like better.
- Second-quarter revenue rose 19% year over year to $94.5 million, but weaker utilization at legacy
ePlus Q1 Earnings Call Highlights
Key Points
- Interested in ePlus inc.? Here are five stocks we like better.
- Revenue rose modestly, but profitability declined: Fiscal Q1 2027 net sales increased 1% to $649.1 million, while
Precigen Q2 Earnings Call Highlights
Key Points
- Interested in Precigen, Inc.? Here are five stocks we like better.
- PAPZIMEOS drove a major commercial acceleration: Second-quarter revenue reached $53.1 million, up more than 145%
Paylocity Q4 Earnings Call Highlights
Key Points
- Interested in Paylocity Holding Corporation? Here are five stocks we like better.
- Paylocity delivered solid fiscal 2026 results: Total revenue rose 11% to approximately $1.8 billion
Pacira BioSciences Q2 Earnings Call Highlights
Key Points
- Interested in Pacira BioSciences, Inc.? Here are five stocks we like better.
- Second-quarter revenue rose 6% to $192.4 million, driven by EXPAREL, ZILRETTA and iovera° sales
Upstart Q2 Earnings Call Highlights
Key Points
- Interested in Upstart Holdings, Inc.? Here are five stocks we like better.
- Upstart delivered strong Q2 growth and returned to profitability: Originations rose 50% year over year to
Tigo Energy Q2 Earnings Call Highlights
Key Points
- Interested in Tigo Energy, Inc.? Here are five stocks we like better.
- Q2 revenue rose 5.6% year over year to $25.4 million, but missed expectations as residential solar markets
Travere Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Travere Therapeutics, Inc.? Here are five stocks we like better.
- Record FILSPARI performance: Travere reported $169.6 million in total second-quarter revenue
TransMedics Group Q2 Earnings Call Highlights
Key Points
- Interested in TransMedics Group, Inc.? Here are five stocks we like better.
- Record Q2 performance: Revenue rose 21% year over year to approximately $190 million, driven by 28% liver
Latham Group Q2 Earnings Call Highlights
Key Points
- Interested in Latham Group, Inc.? Here are five stocks we like better.
- Q2 sales grew 14% year over year to $197 million, driven by 23% growth in in-ground pools, demand for fiberglass